Ind-Swift Laboratories has received approval from board of directors to sell wholly owned subsidiary namely ‘M/s. Halcyon life Sciences’ to ‘M/s. RN Chemicals & Pharmaceutical’ for Rs 50 lakh. The Audit Committee and Board of the Directors of the Company at its meeting held on March 30, 2023 has approved the same. Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).